Factors Associated With Enhanced Low‐Density Lipoprotein Cholesterol Lowering With Bempedoic Acid

Background Bempedoic acid (BA) inhibits ATP‐citrate lyase in the cholesterol synthesis pathway and lowers low‐density lipoprotein cholesterol (LDL‐C). As with other lipid‐lowering therapies, interindividual variation in response to BA was observed in clinical trials. We characterized LDL‐C response...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Christie M. Ballantyne, Harold E. Bays, Michael J. Louie, Jeremy Smart, Yang Zhang, Kausik K. Ray
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2022-08-01
Edice:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Témata:	atherosclerotic cardiovascular disease statin intolerance
On-line přístup:	https://www.ahajournals.org/doi/10.1161/JAHA.121.024531
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!